...
首页> 外文期刊>Liver research. >Necroptosis in ischemia-reperfusion injury of lean and steatotic livers
【24h】

Necroptosis in ischemia-reperfusion injury of lean and steatotic livers

机译:瘦弱的瘦弱性肝脏缺血再灌注损伤的虐待

获取原文

摘要

Hepatic ischemia-reperfusion (IR) injury is a major complication during liver transplantation, liver resection, and other clinical situations. Increased hepatic IR injury in steatotic livers is a major reason for rejecting the use of steatotic livers for liver transplantation. Necroptosis is implicated in the pathogenesis of fatty liver diseases, including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). Necroptosis is one type of regulated cell death and is regulated by three key proteins: receptor-interacting protein 1 (RIP1), receptor-interacting protein 3 (RIP3), and mixed-lineage kinase domain-like protein (MLKL). In this review, we examine the necroptosis status in the steatotic liver diseases NAFLD and ALD as well as its role in hepatic IR injury of lean and steatotic livers.
机译:肝脏缺血再灌注(IR)损伤是肝移植,肝切除和其他临床情况下的主要复杂性。荒谬的肝脏中肝脏IR损伤的增加是拒绝使用臭臭肝脏进行肝移植的主要原因。 Necroptis涉及脂肪肝疾病的发病机制,包括非酒精脂肪肝病(NAFLD)和酒精性肝病(ALD)。 Necroptis是一种调节的细胞死亡,并受三个关键蛋白质调节:受体相互作用蛋白1(RIP1),受体相互作用蛋白3(RIP3)和混合谱系激酶畴样蛋白(MLK1)。在这篇综述中,我们研究了荒谬的肝脏疾病NAFLD和ALD中的坏凋亡状态,以及其在瘦肉和荒谬肝脏伤害中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号